PlainRecalls

Rhodes Pharmaceuticals, L.P.

Compiled from official public sources by the publisher.

2 recalls on record · Latest: Sep 22, 2021

Subscribe to new Rhodes Pharmaceuticals, L.P. recalls (RSS)

Agency notice ledger

Federal filing book Rhodes Pharmaceuticals, L.P. LIGHT-BOOK · SINGLE-AGENCY

#5,659 of 14,151 · 2 notices · 0.002% archive

  • BOOK 2 notices
  • RANK #5,659 of 14,151
  • SHARE 0.002% archive
  • AGENCY FDA Drug (2)
  • CAT drugs
  • CATS 2 categories
  • LATEST Sep 22, 2021
  • PHOTO 3M Company

Nearest notice-volume peer: 3M Company (0 notice gap)

Rhodes Pharmaceuticals, L.P. accounts for about 0.002% of the 104,423-notice archive on 2 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Rhodes Pharmaceuticals, L.P. compares to 14,151 recalling firms

Rhodes Pharmaceuticals, L.P. ranks 5,659th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Rhodes Pharmaceuticals, L.P. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

2 5659th of 14151 higher than 8,037 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Rhodes Pharmaceuticals, L.P. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Rhodes Pharmaceuticals, L.P. holds about 0.002% of archive notices alongside 2 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Sep 22, 2021

Oxycodone Hydrochloride Tablets, USP, 10 mg, 100 count bottle, Rx only, Marketed by: Rhodes Pharmaceuticals L.P., Coventry RI 02816, Manufactured by: Purdue Pharma L.P., Stanford, CT 06901 NDC 42858-002-01
FDA Drug Low May 9, 2018

Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45

Rhodes Pharmaceuticals, L.P. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Aaa Cosmetica, Sa de Cv 2 Abc Sales 1 Inc 2 Abrams Royal Pharamacy 2 Acme United, of Rocky Mount, North Carolina 2

Frequently Asked Questions

How many federal recall notices name Rhodes Pharmaceuticals, L.P.? ▼
PlainRecalls indexes 2 distinct federal recall events naming Rhodes Pharmaceuticals, L.P., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Rhodes Pharmaceuticals, L.P. sit among other recalling firms? ▼
Rhodes Pharmaceuticals, L.P. ranks #5,659 of 14,151 by distinct recall-event count among 14,151 firms in this archive (57th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Rhodes Pharmaceuticals, L.P.'s notices? ▼
FDA Drug accounts for 2 of this firm's 2 indexed notices.
What product category dominates Rhodes Pharmaceuticals, L.P.'s filing book? ▼
Filings for Rhodes Pharmaceuticals, L.P. span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Rhodes Pharmaceuticals, L.P.: 2 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Rhodes Pharmaceuticals, L.P.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026